Genworth Financial (GNW) Holder New Generation Advisors Raised Position by $1.82 Million; As Medtronic Plc (MDT) Market Value Rose, Rock Springs Capital Management LP Cut by $11.75 Million Its Holding

January 22, 2018 - By Louis Casey

Rock Springs Capital Management Lp decreased its stake in Medtronic Plc (MDT) by 38.16% based on its latest 2017Q3 regulatory filing with the SEC. Rock Springs Capital Management Lp sold 152,636 shares as the company’s stock rose 5.51% with the market. The hedge fund held 247,364 shares of the electromedical & electrotherapeutic apparatus company at the end of 2017Q3, valued at $19.24 million, down from 400,000 at the end of the previous reported quarter. Rock Springs Capital Management Lp who had been investing in Medtronic Plc for a number of months, seems to be less bullish one the $117.32B market cap company. The stock decreased 0.66% or $0.58 during the last trading session, reaching $86.68. About 7.31M shares traded or 34.93% up from the average. Medtronic plc (NYSE:MDT) has risen 4.04% since January 22, 2017 and is uptrending. It has underperformed by 12.66% the S&P500.

New Generation Advisors Llc increased its stake in Genworth Financial Inc (GNW) by 56.77% based on its latest 2017Q3 regulatory filing with the SEC. New Generation Advisors Llc bought 605,604 shares as the company’s stock declined 8.54% while stock markets rallied. The hedge fund held 1.67M shares of the life insurance company at the end of 2017Q3, valued at $6.44 million, up from 1.07M at the end of the previous reported quarter. New Generation Advisors Llc who had been investing in Genworth Financial Inc for a number of months, seems to be bullish on the $1.67 billion market cap company. The stock increased 5.03% or $0.16 during the last trading session, reaching $3.34. About 6.43M shares traded or 52.89% up from the average. Genworth Financial, Inc. (NYSE:GNW) has risen 3.41% since January 22, 2017 and is uptrending. It has underperformed by 13.29% the S&P500.

Analysts await Medtronic plc (NYSE:MDT) to report earnings on February, 20. They expect $1.17 EPS, up 4.46% or $0.05 from last year’s $1.12 per share. MDT’s profit will be $1.58B for 18.52 P/E if the $1.17 EPS becomes a reality. After $1.07 actual EPS reported by Medtronic plc for the previous quarter, Wall Street now forecasts 9.35% EPS growth.

Investors sentiment increased to 1.12 in Q3 2017. Its up 0.22, from 0.9 in 2017Q2. It is positive, as 73 investors sold MDT shares while 392 reduced holdings. 109 funds opened positions while 414 raised stakes. 1.07 billion shares or 1.07% more from 1.06 billion shares in 2017Q2 were reported. Ci Investments holds 926,000 shares. Hightower Advsr Limited Liability invested in 0.13% or 190,088 shares. Bartlett & Lc invested 0.01% in Medtronic plc (NYSE:MDT). Hikari Power Ltd holds 50,700 shares. Paradigm Asset Mngmt Ltd holds 0.02% or 1,200 shares. Federated Pa holds 0.04% or 166,443 shares in its portfolio. Neville Rodie And Shaw has invested 0.16% in Medtronic plc (NYSE:MDT). Commonwealth Equity Services stated it has 0.08% in Medtronic plc (NYSE:MDT). First City Mngmt Inc holds 0.41% of its portfolio in Medtronic plc (NYSE:MDT) for 7,455 shares. Cleararc Capital owns 37,300 shares or 0.44% of their US portfolio. Glenview Commercial Bank Dept has 4,696 shares for 0.18% of their portfolio. 41,000 are owned by Cornerstone Advsr Inc. Retirement Of Alabama reported 992,185 shares. Strategic Finance Services accumulated 57,716 shares. Two Sigma Limited Liability Company holds 0.11% of its portfolio in Medtronic plc (NYSE:MDT) for 15,167 shares.

Rock Springs Capital Management Lp, which manages about $319.00M and $2.17B US Long portfolio, upped its stake in Radius Health Inc (NASDAQ:RDUS) by 32,750 shares to 943,000 shares, valued at $36.35M in 2017Q3, according to the filing. It also increased its holding in Invitae Corp by 106,000 shares in the quarter, for a total of 1.31M shares, and has risen its stake in Neurocrine Biosciences Inc (NASDAQ:NBIX).

Among 28 analysts covering Medtronic (NYSE:MDT), 19 have Buy rating, 0 Sell and 9 Hold. Therefore 68% are positive. Medtronic had 78 analyst reports since August 10, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Monday, November 23 by Credit Suisse. The company was maintained on Tuesday, November 21 by Jefferies. Wedbush maintained the shares of MDT in report on Wednesday, June 1 with “Neutral” rating. The firm has “Hold” rating given on Tuesday, July 18 by Stifel Nicolaus. On Thursday, July 6 the stock rating was maintained by William Blair with “Outperform”. The stock of Medtronic plc (NYSE:MDT) earned “Buy” rating by Needham on Wednesday, February 22. The firm has “Buy” rating by RBC Capital Markets given on Sunday, August 20. As per Wednesday, April 19, the company rating was maintained by RBC Capital Markets. The rating was maintained by Needham with “Buy” on Wednesday, November 23. The rating was maintained by Needham on Tuesday, September 5 with “Buy”.

Among 8 analysts covering Genworth Financial (NYSE:GNW), 1 have Buy rating, 1 Sell and 6 Hold. Therefore 13% are positive. Genworth Financial had 22 analyst reports since August 5, 2015 according to SRatingsIntel. The firm has “Buy” rating by Compass Point given on Monday, February 8. The stock of Genworth Financial, Inc. (NYSE:GNW) earned “Neutral” rating by Goldman Sachs on Tuesday, November 17. The rating was downgraded by BTIG Research on Wednesday, October 5 to “Neutral”. The firm earned “Hold” rating on Tuesday, August 1 by Wells Fargo. The stock has “Market Perform” rating by Wells Fargo on Friday, September 23. UBS maintained the stock with “Neutral” rating in Tuesday, September 8 report. The stock has “Buy” rating by Compass Point on Friday, November 11. The rating was maintained by Keefe Bruyette & Woods on Friday, November 3 with “Hold”. As per Wednesday, November 4, the company rating was downgraded by UBS. The stock of Genworth Financial, Inc. (NYSE:GNW) earned “” rating by Wood on Wednesday, September 2.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.